Catherine Wood, chief executive officer of ARK Investment Management LLC, speaks during the Milken Institute Global Conference in Beverly Hills, California, on Monday, Oct. 18, 2021.
Kyle Grillot | Bloomberg | Getty Images
Gene-editing stocks may have disappointed lately but Cathie Wood still sees them as a big opportunity for long-term investors, and highlighted three favorites.
Let’s get ready to rumble. The Federal Reserve and investors appear to be locked in what one veteran market watcher...
Investors have faced a conundrum in valuing companies that benefited from the Covid-19 pandemic. Pfizer's (PFE) partnership with BioNTech (BNTX)...
S&P Futures 4,079.00 -5.25(-0.13%) Dow Futures 34,002.00 -44.00(-0.13%) Nasdaq Futures 12,209.50 -12.75(-0.10%) Russell 2000 Futures 1,916.00 -3.50(-0.18%)...
S&P Futures 4,073.00 -11.25(-0.28%) Dow Futures 33,973.00 -73.00(-0.21%) Nasdaq Futures 12,177.50 -44.75(-0.37%) Russell 2000 Futures 1,913.50 -6.00(-0.31%)...
European stocks are are having a good year so far. The benchmark Stoxx 600 is up around 7% since the...
Please Enter Your Email Address:
By opting in you agree to our Privacy Policy. You also agree to receive emails from us and our affiliates. Remember that you can opt-out any time, we hate spam too!
